Literature DB >> 3934814

Comparisons of immunological tests for serodiagnosis of Chagas disease in Bolivian patients.

S F Breniere, R Carrasco, H Miguez, J L Lemesre, Y Carlier.   

Abstract

Enzyme linked immunosorbent assay (ELISA) and immunoelectrophoresis (IEP) were evaluated and compared to the classical immunofluorescence (IF) and complement fixation test (CFT) in the immunological diagnosis of Chagas' disease, using 407 sera from Bolivian patients. 72.7 to 79.5% of randomised sera, coming from patients living in endemic areas for Chagas' disease were considered as positive, according to the test limits, previously determined. The techniques could be classified according to their percentage detection as ELISA greater than IF greater than CFT greater than IEP. The quantitative correlations between the tests were excellent (p less than 0.001). 92.8% of the sera were positive or negative for the four tests, 6.1% for three tests and 1.1% for only two tests. The agreement between the tests ranged from 94.6 to 99.2%, co-positivity from 95.5 to 100% and co-negativity from 88.5 to 100%. IF gave the best results, and could be considered as the reference test since it was easy and rapid to perform. However to avoid errors or discrepancies between laboratories, two tests, such as IF and CFT, might be associated. ELISA can be used if higher sensitivity is required. IEP showed 1 to 14 precipitation bands in 96% of the sera from infected patients. The precipitation band 5, previously demonstrated as Trypanosoma cruzi specific, was present in 73% of these sera, indicating the interest to use immunoprecipitation test, if more specificity is required for the immunodiagnosis of Chagas' disease.

Entities:  

Mesh:

Year:  1985        PMID: 3934814

Source DB:  PubMed          Journal:  Trop Geogr Med        ISSN: 0041-3232


  7 in total

1.  Development and comparison of enzyme immunoassays for diagnosis of Chagas' disease using fixed forms of Trypanosoma cruzi (Epimastigotes, Amastigotes, and Trypomastigotes) and assessment of antigen stability for the three assays.

Authors:  Mariolga Berrizbietia; Momar Ndao; Marcelo Gottschalk; Alberto Aché; Fabio Vásquez; Sonia Lacouture; Mehudy Medina; Brian J Ward
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

2.  Congenital Trypanosoma cruzi infection in neonates and infants from two regions of Chile where Chagas' disease is endemic.

Authors:  Maria I Jercic; Ruben Mercado; Rodrigo Villarroel
Journal:  J Clin Microbiol       Date:  2010-08-04       Impact factor: 5.948

3.  Pregnancy and humoral immune response in mice chronically infected by Trypanosoma cruzi.

Authors:  Y Carlier; M T Rivera; C Truyens; M Goldman; P Lambert; J Flament; D Bauwens; B Vray
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

4.  Purified excreted-secreted antigens from Trypanosoma cruzi trypomastigotes as tools for diagnosis of Chagas' disease.

Authors:  Mariolga Berrizbeitia; Momar Ndao; José Bubis; Marcelo Gottschalk; Alberto Aché; Sonia Lacouture; Mehudy Medina; Brian J Ward
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

5.  Maternal Trypanosoma cruzi infection upregulates capacity of uninfected neonate cells To produce pro- and anti-inflammatory cytokines.

Authors:  J Vekemans; C Truyens; F Torrico; M Solano; M C Torrico; P Rodriguez; C Alonso-Vega; Y Carlier
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

6.  Rapid immunochromatographic tests for the diagnosis of chronic Chagas disease in at-risk populations: A systematic review and meta-analysis.

Authors:  Andrea Angheben; Dora Buonfrate; Mario Cruciani; Yves Jackson; Julio Alonso-Padilla; Joaquim Gascon; Federico Gobbi; Giovanni Giorli; Mariella Anselmi; Zeno Bisoffi
Journal:  PLoS Negl Trop Dis       Date:  2019-05-31

7.  Chagas disease, France.

Authors:  François-Xavier Lescure; Ana Canestri; Hugues Melliez; Stéphane Jauréguiberry; Michel Develoux; Richard Dorent; Jean-Baptiste Guiard-Schmid; Philippe Bonnard; Faïza Ajana; Valeria Rolla; Yves Carlier; Frederick Gay; Marie-Hélène Elghouzzi; Martin Danis; Gilles Pialoux
Journal:  Emerg Infect Dis       Date:  2008-04       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.